These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37450960)

  • 21. Antimicrobial Locks in Patients Receiving Home Parenteral Nutrition.
    Daoud DC; Wanten G; Joly F
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32050544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of telavancin and vancomycin lock solutions in eradication of biofilm-producing staphylococci and enterococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2016 Mar; 73(5):315-21. PubMed ID: 26896504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of taurolidine-citrate in a cohort of patients with intestinal failure receiving home parenteral nutrition.
    Williams TJ; Moy N; Kaazan P; Callaghan G; Holtmann G; Martin N
    JPEN J Parenter Enteral Nutr; 2024 Feb; 48(2):165-173. PubMed ID: 38062902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 2% taurolidine catheter lock solution prevents catheter-related bloodstream infection (CRBSI) and catheter dysfunction in hemodialysis patients.
    Neusser MA; Bobe I; Hammermeister A; Wittmann U
    Br J Nurs; 2021 Jul; 30(14):S24-S32. PubMed ID: 34288746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm.
    Percival SL; Kite P; Eastwood K; Murga R; Carr J; Arduino MJ; Donlan RM
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):515-9. PubMed ID: 16018425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
    Longo R; Llorens M; Goetz C; Platini C; Eid N; Sellies J; Ouamara N; Quétin P
    Oncology; 2017; 93(2):99-105. PubMed ID: 28463827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of N-acetyl cysteine and levofloxacin as a catheter lock therapy against catheter-associated infections.
    Mansouri MD; Ramanthan V; Mansouri DL; Hull RA
    J Appl Microbiol; 2022 May; 132(5):3915-3924. PubMed ID: 35157342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bloodstream Infections in the Intensive Care Unit: a Single-Center Retrospective Bacteriological Analysis Between 2007 and 2019.
    Guzek A; Rybicki Z; Woźniak-Kosek A; Tomaszewski D
    Pol J Microbiol; 2022 Jun; 71(2):263-277. PubMed ID: 35716169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions.
    Olthof ED; Versleijen MW; Huisman-de Waal G; Feuth T; Kievit W; Wanten GJ
    PLoS One; 2014; 9(11):e111216. PubMed ID: 25379781
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Reidenberg BE; Jenkins SG; Crandon JL; Hurlburt E; Tan X; Rhomberg PR; Arends SJR; Pfaffle A
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0038124. PubMed ID: 38864612
    [No Abstract]   [Full Text] [Related]  

  • 31. Microbiology and prevalence of E
    de la Cruz-Hernández I; Cornejo-Juárez P; Tellez-Miranda O; Barrera-Pérez L; Sandoval-Hernández S; Vilar-Compte D; Velázquez-Acosta C; Volkow P
    Am J Infect Control; 2020 Jan; 48(1):40-45. PubMed ID: 31395288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition.
    Wouters Y; Theilla M; Singer P; Tribler S; Jeppesen PB; Pironi L; Vinter-Jensen L; Rasmussen HH; Rahman F; Wanten GJA
    Aliment Pharmacol Ther; 2018 Aug; 48(4):410-422. PubMed ID: 29978597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapsing peritonitis and taurolidine peritoneal catheter lock: One center experience.
    Sosa Barrios RH; Álvarez Nadal M; Burguera Vion V; Campillo Trapero C; López Melero E; Fernández Lucas M; Rivera Gorrín ME
    J Vasc Access; 2021 Mar; 22(2):261-265. PubMed ID: 32605474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candida catheter-related bloodstream infection in patients on home parenteral nutrition - Rates, risk factors, outcomes, and management.
    Phua AI; Hon KY; Holt A; O'Callaghan M; Bihari S
    Clin Nutr ESPEN; 2019 Jun; 31():1-9. PubMed ID: 31060825
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Vargas-Cruz N; Reitzel RA; Rosenblatt J; Jamal M; Szvalb AD; Chaftari AM; Hachem R; Raad I
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital.
    Hashem AA; Abd El Fadeal NM; Shehata AS
    J Med Microbiol; 2017 Jun; 66(6):744-752. PubMed ID: 28598310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections.
    Bookstaver PB; Williamson JC; Tucker BK; Raad II; Sherertz RJ
    Ann Pharmacother; 2009 Feb; 43(2):210-9. PubMed ID: 19193593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and economic impact of the taurolidine lock on home parenteral nutrition.
    Arnoriaga Rodríguez M; Pérez de Ciriza Cordeu M; Camblor Álvarez M; Bretón Lesmes I; Motilla de la Cámara M; Velasco Gimeno C; Arhip L; García Peris P; Cuerda Compés C
    Nutr Hosp; 2018 Jun; 35(4):761-766. PubMed ID: 30070861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.